Femtech Canada expands support network with launch of wHealth MedPath program for start-ups
The wHealth MedPath program is designed to support validation to scale-stage- companies developing innovative solutions in the femtech health and wellness space. Eligible Canadian femtech companies can leverage up to $20,000 worth in services designed to bridge the gap between innovation and market implementation. Whether you’re looking to advance clinical validation, shape your market strategy or navigate compliance pathways with confidence, wHealth MedPath is designed to support the unique commercialization pathways of femtech companies.
Femtech Canada’s wHealth MedPath program is delivered in partnership with Innovation Factory, and supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).
Timeline:
Due to the limited number of project support available, applicants are encouraged to apply before August 30, 2025.
wHealth Medpath applications are reviewed on a first-come, first-served basis until March 31, 2026 or until funding is fully committed.